Salivary Gland Cancer

Our head and neck specialists are experienced in using highly technical procedures to remove salivary gland cancer while preserving or reconstructing important nerves. A team of experts, including ear, nose, and throat specialists called otolaryngologists, surgeons, radiation oncologists, and medical oncologists, works together to provide evidence-based, compassionate care. Rehabilitation experts manage any treatment-related side effects, and integrative medicine specialists offer services to support your overall wellbeing.

Clinical Trials and Research Studies

Phase 6

RANDOMIZED PHASE II/III TRIAL OF SENTINEL LYMPH NODE BIOPSY VERSUS ELECTIVE NECK DISSECTION FOR EARLY-STAGE ORAL CAVITY CANCER

Learn More

Phase 1

Phase 1 Open-Label Multicenter Dose Escalation Study of mRNA-2752 a Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L IL-23 and IL-36? for Intratumoral Injection Alone and in Combination with Immune Checkpoint Blockade

Learn More

Phase 5

A Phase 1/2a Multi-Center Open-Label Study to Evaluate the Safety Tolerability Pharmacokinetics and Preliminary Evidence of Antitumor Activity of JAB-3312 in combination with pembrolizumab or binimetinib in Adult Patients with Advanced Solid Tumors

Learn More

Phase 2

A Phase 2 randomized open-label three-arm clinical study to evaluate the safety and efficacy of lenvatinib (E7080/MK-7902) in combination with pembrolizumab (MK-3475) versus standard of care chemotherapy and lenvatinib monotherapy in participants with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) that have progressed after platinum therapy and immunotherapy (PD-1/PD-L1 inhibitors) (LEAP-009)

Learn More